تجاوز إلى المحتوى الرئيسي
drug protocol number
GBT2104-133
drug sponsor
Global Blood Therapeutics (GBT)
drug study
Inclacumab
drug trial site
Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabi
drug status
Ongoing
drug phase